Home > PE Ratio > NGL FINECHEM

NGL FINECHEM
PE (Price/Earnings) Ratio

The Current P/E Ratio of NGL FINECHEM is 26.85.

Share Price ₹1,792.4Nov 19,2024
Market Cap ₹1,111.3 Cr
Earnings-TTM₹41.4 CrTTM-Consolidated Results
Price/Earnings26.85xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
NGL FINECHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of NGL FINECHEM

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of NGL FINECHEM is calculated as :

Current Market Cap [ ₹1,111.3 Cr] as on Nov 19,2024

(/) Earnings [ ₹41.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 26.85x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for NGL FINECHEM , the investors are currently willing to pay 26.85 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NGL FINECHEM !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of NGL FINECHEM over the last five years.

Historical PE (Price/Earnings) ratio chart of NGL FINECHEM


PE Ratio Performance Analysis for NGL FINECHEM

- NGL FINECHEM 's latest p/e ratio is 26.85x.

- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 25.58x.

- NGL FINECHEM 's operated at median p/e ratio of 24.27x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2023 at 36.22x.

- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2021 of 16.74x.


How does NGL FINECHEM 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
NGL FINECHEM 41.3926.851,111.3
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.25425,930.0
CIPLA LTD4,485.2226.49118,828.0
DR REDDYS LABORATORIES LTD5,406.8018.73101,290.0
ZYDUS LIFESCIENCES LTD4,298.9022.1695,280.3
DIVIS LABORATORIES LTD1,836.0085.25156,524.0
MANKIND PHARMA LTD2,124.8648.42102,890.0
TORRENT PHARMACEUTICALS LTD1,802.0058.13104,742.0
LUPIN LTD2,651.9435.0492,929.7
AUROBINDO PHARMA LTD3,598.8320.1472,478.2
ABBOTT INDIA LTD1,284.6644.9857,784.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NGL FINECHEM 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.73x
Max industry PE 85.25x
Median industry PE 35.04x
Average industry PE 38.59x



You may also like the below Video Courses